• $925,538.00
    Market Cap
  • -29.50%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
3.9M
-41.12%
6.6M
+77.19%
3.7M
N/A
0
-100.00%
Cost of Revenue
1.8M
-36.74%
2.9M
+38.80%
2.1M
-21.65%
2.6M
+10,442.56%
Gross Profit
2.1M
-44.49%
3.7M
+125.09%
1.7M
-32.65%
2.5M
+49,047.76%
Sales and Marketing Expense
7,302
0.00%
7,302
+934.28%
706
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
898,403
-1.94%
916,213
+12.88%
811,649
-8.31%
885,229
-8.88%
Total Operating Expenses
2.3M
-12.23%
2.6M
+25.03%
2.1M
+68.32%
1.2M
-8.16%
Operating Profit
-1.4M
-947.13%
160,504
+149.59%
-323,670
-92.84%
-4.5M
-1,756.42%
Interest Income
34,062
+10.52%
30,821
+83.66%
16,782
-97.93%
811,464
+2,537.28%
Interest Expense
-38
0.00%
-38
-100.00%
-1.4M
+25.80%
-1.1M
+13.79%
Interest Income and Expense and Net
34,024
+10.53%
30,783
+102.21%
-1.4M
+349.55%
-310,131
-67.52%
Total Nonoperating Income and Expense
-1.1M
+19.01%
-956,212
-988.60%
107,609
+103.28%
-3.3M
-302.18%
Income before Taxes
-1.4M
-947.13%
160,504
+149.59%
-323,670
-92.84%
-4.5M
-1,756.42%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.4M
-947.13%
160,504
+149.59%
-323,670
-92.84%
-4.5M
-1,756.42%
Net Income from Continuing Operations Applicable to Common
-1.4M
-947.13%
160,504
+149.59%
-323,670
-92.84%
-4.5M
-1,756.42%
Basic EPS and Net Income
-0.002
-833.33%
0.0003
+160.00%
-0.0005
-93.15%
-0.007
-1,560.00%
Diluted EPS and Net Income
-0.002
-1,200.00%
0.0002
+140.00%
-0.0005
-93.15%
-0.007
-1,560.00%
Basic Weighted Average Shares
617.0M
0.00%
617.0M
0.00%
617.0M
0.00%
617.0M
+3.64%
Diluted Weighted Average Shares
617.0M
-15.15%
727.2M
+17.86%
617.0M
0.00%
617.0M
+3.64%
Balance Sheet
Cash and Cash Equivalents
100,410
-94.63%
1.9M
+153.93%
736,323
+228.95%
223,843
+97.95%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
100,410
-94.63%
1.9M
+153.93%
736,323
+228.95%
223,843
+97.95%
Total Current Assets
2.3M
-24.90%
3.1M
+0.25%
3.1M
+240.03%
909,987
+55.76%
Accumulated Depreciation
945,131
+31.93%
716,407
-80.76%
3.7M
+39.29%
2.7M
+40.99%
Property and Plant and Equipment and Net
3.6M
-15.08%
4.2M
-22.92%
5.4M
-2.23%
5.6M
-18.82%
Total Long-Term Assets
3.8M
-13.96%
4.5M
-22.19%
5.7M
-13.66%
6.7M
-46.66%
Total Assets
6.2M
-18.44%
7.6M
-14.34%
8.8M
+16.86%
7.6M
-42.08%
Income Taxes Payable
0
N/A
0
-100.00%
48,581
+37.80%
35,254
N/A
Total Short-Term Debt
480
0.00%
480
0.00%
480
0.00%
480
0.00%
Total Current Liabilities
13.4M
+2.18%
13.1M
-10.23%
14.6M
+110.60%
6.9M
+71.33%
Total Long-Term Debt
7.6M
+4.98%
7.2M
-8.08%
7.9M
-42.28%
13.7M
-16.18%
Total Long-Term Liabilities
858,088
-12.86%
984,733
-19.57%
1.2M
-82.99%
7.2M
-35.57%
Total Liabilities
14.2M
+1.13%
14.1M
-10.96%
15.8M
+11.95%
14.1M
-7.16%
Retained Earnings
-32.3M
+4.39%
-30.9M
-0.52%
-31.1M
+1.05%
-30.8M
+17.21%
Total Stockholders Equity
-8.1M
+23.90%
-6.5M
-6.67%
-7.0M
+6.29%
-6.6M
+204.81%
Total Shares Outstanding
617.0M
0.00%
617.0M
0.00%
617.0M
0.00%
617.0M
0.00%
Cash Flow
Cash from Operating Activities
-842,425
-138.95%
2.2M
+466.80%
-589,612
-41.90%
-1.0M
-1,113.63%
Capital Expenditures
74,627
+7.46%
69,444
+214.43%
22,086
+6,933.76%
314
+102.64%
Cash from Investing Activities
81,379
+145.47%
-178,978
-142.93%
416,932
-58.92%
1.0M
+172.20%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-1.1M
+45.82%
-730,225
-209.50%
666,900
+443.64%
122,674
-90.20%
Financials Ratio
Gross Margin
53.28%
-5.72%
56.51%
+27.03%
44.49%
N/A
N/A
N/A
Operating Margin
-35.03%
-1,538.78%
2.44%
+127.99%
-8.70%
N/A
N/A
N/A
Return on Assets
-19.78%
-1,111.29%
1.96%
+149.56%
-3.95%
-91.00%
-43.82%
-2,195.71%
Return on Equity
18.66%
+883.75%
-2.38%
-149.78%
4.78%
-95.39%
103.77%
+1,178.68%
Revenue Growth
-41.12%
-153.28%
77.19%
N/A
N/A
N/A
-100.00%
N/A
Current Ratio
0.17
-26.48%
0.24
+11.65%
0.21
+61.42%
0.13
-9.07%
Cash Ratio
0.008
-94.75%
0.14
+182.77%
0.05
+56.35%
0.03
+15.36%
Debt-to-Equity Ratio
-0.94
-15.27%
-1.11
-1.51%
-1.13
-45.70%
-2.08
-72.50%
Debt-to-Assets Ratio
1.23
+28.72%
0.96
+7.30%
0.89
-50.61%
1.80
+44.72%

Earnings & Revenue History

Debt-to-Assets

Cash Flow